L
Laurence Collette
Researcher at European Organisation for Research and Treatment of Cancer
Publications - 281
Citations - 37642
Laurence Collette is an academic researcher from European Organisation for Research and Treatment of Cancer. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 78, co-authored 276 publications receiving 33811 citations. Previous affiliations of Laurence Collette include VU University Amsterdam & Université catholique de Louvain.
Papers
More filters
Journal ArticleDOI
What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question?
F. Bonnetain,J.-F. Bosset,Jean-Pierre Gerard,Gilles Calais,T. Conroy,Laurent Mineur,O. Bouche,P. Maingon,O. Chapet,L. Radosevic-Jelic,N. Methy,Laurence Collette +11 more
TL;DR: Preoperative CRT does not prolong OS or PFS and pCR or LC do not qualify as surrogate for PFS or OS while PFS is surrogate.
Journal ArticleDOI
A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992)
Christine Theodore,I. Skoneczna,István Bodrogi,M. G. Leahy,J.M. Kerst,Laurence Collette,K. Ven,Sandrine Marreaud,R.D.T. Oliver +8 more
TL;DR: The study fails to demonstrate a response rate significantly >30% and the observation regarding M0 patients suggests to repeat this study in the neo-adjuvant setting.
Journal ArticleDOI
Long-Term Follow-Up of an EORTC Randomized Prospective Trial Comparing Intravesical Bacille Calmette-Guerin-RIVM and Mitomycin C in Superficial Bladder Cancer
J.A. Witjes,Adrian P.M. van der Meijden,Laurence Collette,Richard Sylvester,Frans M.J. Debruyne,A. van Aubel,Wim P.J. Witjes +6 more
TL;DR: Of the 33 patients with tumor progression after intravesical therapy, 20 died of bladder cancer, confirming that tumor progression afterwards carries a poor prognosis, and the difference in toxicity between BCG and MMC was not significant.
Journal ArticleDOI
Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group
Frédéric Lecouvet,Daniela E. Oprea-Lager,Yan Liu,Piet Ost,Luc Bidaut,Laurence Collette,Christophe Deroose,Karolien Goffin,Ken Herrmann,Otto S. Hoekstra,Gem Kramer,Yolande Lievens,Egesta Lopci,David Pasquier,Lars Jelstrup Petersen,Jean-Noël Talbot,Helle D Zacho,Bertrand Tombal,Nandita M. deSouza +18 more
TL;DR: This Review assesses imaging methods used to identify metastatic prostate cancer at first diagnosis, at biochemical recurrence, or at the castration-resistant stage.
Journal ArticleDOI
Radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM): Interim results of a randomised phase II study of the EORTC-NCRI CCSG-ALM Intergroup 40004 (CLOCC)
T. Ruers,F Van Coevorden,Jean-Pierre E. N. Pierie,I. H. M. Borel Rinkes,C.J.A. Punt,Jonathan A. Ledermann,Graeme J. Poston,Wolf O. Bechstein,M.A. Lentz,Laurence Collette,Bernard Nordlinger +10 more
TL;DR: In this article, the authors evaluated the benefit of combining CT with local tumor destruction by RFA in patients with unresectable CRC lesions up to 9 lesions and without extrahepatic disease.